160.97
Schlusskurs vom Vortag:
$161.93
Offen:
$160.5
24-Stunden-Volumen:
1.17M
Relative Volume:
0.13
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-2.77%
1M Leistung:
+2.17%
6M Leistung:
+26.48%
1J Leistung:
+69.28%
State Street Spdr S P Biotech Etf Stock (XBI) Company Profile
Firmenname
State Street Spdr S P Biotech Etf
Sektor
Branche
Telefon
-
Adresse
-
Compare XBI vs VTI, SPY, IVV, VB, QQQ
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
|
XBI
State Street Spdr S P Biotech Etf
|
161.06 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
376.37 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
763.43 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
767.05 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
296.02 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
717.41 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Biotech Etf Aktie (XBI) Neueste Nachrichten
Healthcare ETFs Were Left Behind. JPMorgan Sees the Money Coming Back - Benzinga
IBB Just Beat the S&P 500 by 22 Points in Three Months. Are You Late to the Party? - 24/7 Wall St.
State Street SPDR S&P Biotech ETF (XBI) rated B... - Pluang
XBI: Big Pharma Can Keep The 76% Rally Going (NYSEARCA:XBI) - Seeking Alpha
Should You Invest in the VanEck Biotech ETF (BBH)? - Eastern Progress
Is State Street SPDR S&P Software & Services ETF (XSW) a Strong ETF Right Now? - Yahoo Finance
Biotech Is Popping. No One Seems to Care. - The Daily Upside
What's Going On With Novavax Stock? - Benzinga
The Next Biotech Boom May Be Cancer Vaccines. Watch These ETFsModerna (NASDAQ:MRNA) - Benzinga
Should You Invest in the First Trust NYSE Arca Biotechnology ETF (FBT)? - Eastern Progress
Should You Invest in the State Street SPDR S&P Homebuilders ETF (XHB)? - Yahoo Finance
Trump's Pharma Pricing Deal Expands as Healthcare Stocks Keep Climbing - CryptoRank
Novavax Stock Climbs Monday: What's Going On? - Benzinga
XBI Forecast: $174.79 Tests Biotech ETF Breakout Strength - FXEmpire
Analysts See Drastic Change For This Particular Part Of Healthcare - Investor's Business Daily
Equal-weight S&P 500 is leading the 2026 market and its flagship trade just hit $100 billion - CNBC
IHE vs. XBI: Pharma Stability or Biotech Growth -- Which Healthcare ETF Is the Better Buy? - AOL.com
XBI: Biotech's Breakthrough Moment Happend This Week (Upgrade) (NYSEARCA:XBI) - Seeking Alpha
Moderna just gained $44 billion in value in a few hours - Opening Bell Daily
Merck, Moderna Cancer Vaccine Breakthrough Puts 4 ETFs In FocusMerck & Co (NYSE:MRK) - Benzinga
Biotechs hit a post-pandemic high after mRNA trial win for Moderna, Merck - Seeking Alpha
Novavax Stock Moves Higher Wednesday: What's Driving the Action? - Benzinga
Ishares Biotech ETF up 3.2%, State Street Spd - Moomoo
Healthcare ETFs Are Looking Up: Here's Why - cnhinews.com
XBI vs. FBT: Broad Biotech Exposure or Concentrated Bets? - The Motley Fool
State Street XBI and First Trust FBT Offer Biotech ETF Options - sekbernews.id
Which Healthcare ETF Is the Better Buy: VanEck's Pharma PPH or State Street's Biotech XBI? - The Motley Fool
State Street SPDR S&P Biotech ETF (Derivatives): Latest News, Social Media Updates and Insights - CryptoRank
Should You Invest in the State Street SPDR S&P Software & Services ETF (XSW)? - Yahoo Finance
ETFs Investing in Arrowhead Pharmaceuticals, Inc. Stocks - TradingView
Biotechnology vs. Pharmaceuticals: What Are the Differences? - The Motley Fool
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)? - finance.yahoo.com
Sionna Therapeutics (NASDAQ:SION) Drops 92% After Failed Study, Shares Fall Below Gross Cash - TechStock²
iShares IXJ Competes Against State Street XBI in Healthcare ETF Battle - sekbernews.id
iShares Global Healthcare ETF vs State Street SPDR Biotech ETF. Which Healthcare-Focused Fund Will Bring You Profits in 2026 and Beyond? - The Motley Fool
Biotech Stocks: The New Drugs That Could Fuel Big Gains - Barron's
State Street XLV vs VanEck BBH: Which Healthcare ETF Is the Better Buy in 2026? - The Globe and Mail
State Street Health Care Select Sector SPDR ETF - ETF Database
Which Is the Better State Street Healthcare ETF: The Broad XLV or the Biotech XBI? - The Globe and Mail
Is State Street SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now? - Yahoo Finance
Is State Street SPDR S&P Semiconductor ETF (XSD) a Strong ETF Right Now? - Yahoo Finance
Uniqure NV (QURE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Oric Pharmaceuticals Inc (ORIC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Verastem Inc (VSTM) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Roivant Sciences Ltd (ROIV) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AnaptysBio Inc (ANAB) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Arrivent Biopharma Inc (AVBP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Revolution Medicines Inc (RVMD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Krystal Biotech Inc (KRYS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
MannKind Corp (MNKD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
CRISPR Therapeutics AG (CRSP) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
Finanzdaten der State Street Spdr S P Biotech Etf-Aktie (XBI)
Es liegen keine Finanzdaten für State Street Spdr S P Biotech Etf (XBI) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):